ATG9A and cancer: ATG9A has been reported to protect the plasma membrane from damage caused by microbial and endogenous agents through collaboration with IQGAP1 and the ESCRT system18.We also confirmed enhanced ATG9A-IQGAP1 interaction in co-cultured cancer cell samples compared to cancer-only conditions (Supplementary Fig. 6B).